Literature DB >> 22611443

Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region.

Christof Prugger1, Jan Heidrich, Jürgen Wellmann, Ralf Dittrich, Stefan-Martin Brand, Ralph Telgmann, Günter Breithardt, Holger Reinecke, Hans Scheld, Peter Kleine-Katthöfer, Peter U Heuschmann, Ulrich Keil.   

Abstract

BACKGROUND: Target values for cardiovascular risk factors in patients with coronary heart disease (CHD) are stated in guidelines for the prevention of cardiovascular disease. We studied secular trends in risk factors over a 12-year period among CHD patients in the region of Münster, Germany.
METHODS: The cross-sectional EUROASPIRE I, II and III surveys were performed in multiple centers across Europe. For all three, the Münster region was the participating German region. In the three periods 1995/96, 1999/2000, and 2006/07, the surveys included (respectively) 392, 402 and 457 ≤ 70-year-old patients with CHD in Münster who had sustained a coronary event at least 6 months earlier.
RESULTS: The prevalence of smoking remained unchanged, with 16.8% in EUROASPIRE I and II and 18.4% in EUROASPIRE III (p=0.898). On the other hand, high blood pressure and high cholesterol both became less common across the three EUROASPIRE studies (60.7% to 69.4% to 55.3%, and 94.3% to 83.4% to 48.1%, respectively; p<0.001 for both). Obesity became more common (23.0% to 30.6% to 43.1%, p<0.001), as did treatment with antihypertensive and lipid-lowering drugs (80.4% to 88.6% to 94.3%, and 35.0% to 67.4% to 87.0%, respectively; p<0.001 for both).
CONCLUSION: The observed trends in cardiovascular risk factors under-score the vital need for better preventive strategies in patients with CHD.

Entities:  

Mesh:

Year:  2012        PMID: 22611443      PMCID: PMC3355493          DOI: 10.3238/arztebl.2012.0303

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  42 in total

1.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

Authors:  D Wood; G De Backer; O Faergeman; I Graham; G Mancia; K Pyörälä
Journal:  Atherosclerosis       Date:  1998-10       Impact factor: 5.162

2.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

3.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

Authors: 
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

4.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; M Mähönen; H Tolonen; E Ruokokoski; P Amouyel
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

5.  Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease.

Authors:  L Chambless; U Keil; A Dobson; M Mähönen; K Kuulasmaa; A M Rajakangas; H Löwel; H Tunstall-Pedoe
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

6.  Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

Authors:  Samuel Klein; Lora E Burke; George A Bray; Steven Blair; David B Allison; Xavier Pi-Sunyer; Yuling Hong; Robert H Eckel
Journal:  Circulation       Date:  2004-10-27       Impact factor: 29.690

7.  Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry.

Authors:  K Malmberg; S Yusuf; H C Gerstein; J Brown; F Zhao; D Hunt; L Piegas; J Calvin; M Keltai; A Budaj
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

8.  The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study.

Authors:  H Löwel; W Koenig; S Engel; A Hörmann; U Keil
Journal:  Diabetologia       Date:  2000-02       Impact factor: 10.122

9.  [The Worldwide WHO MONICA Project: results and perspectives].

Authors:  U Keil
Journal:  Gesundheitswesen       Date:  2005-08

10.  Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.

Authors:  M de Lorgeril; P Salen; J L Martin; I Monjaud; J Delaye; N Mamelle
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

View more
  6 in total

1.  Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.

Authors:  Martin Wagner; Götz Gelbrich; Julia Kircher; Kornelia Kotseva; David Wood; Caroline Morbach; Rainer Leyh; Georg Ertl; Wolfgang Karmann; Stefan Störk; Peter U Heuschmann
Journal:  Int J Behav Med       Date:  2018-06

2.  Psychosomatic background of classic cardiovascular risk factors.

Authors:  Bernhard Korbmacher; Ralf Schäfer
Journal:  Dtsch Arztebl Int       Date:  2012-10-26       Impact factor: 5.594

3.  [Prevalence of arterial hypertension in the population of Western Germany: Heinz Nixdorf Recall Study].

Authors:  M Horacek; S Möhlenkamp; A A Mahabadi; S Churzidse; S Moebus; K-H Jöckel; R Erbel
Journal:  Herz       Date:  2012-11       Impact factor: 1.443

4.  Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.

Authors:  S Störk; P U Heuschmann; K Ungethüm; S Wiedmann; M Wagner; R Leyh; G Ertl; S Frantz; T Geisler; W Karmann; R Prondzinsky; C Herdeg; M Noutsias; T Ludwig; J Käs; B Klocke; J Krapp; D Wood; K Kotseva
Journal:  Clin Res Cardiol       Date:  2022-09-27       Impact factor: 6.138

5.  Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany.

Authors:  Ingo Ahrens; Artak Khachatryan; Bondo Monga; Eugen Dornstauder; Eduard Sidelnikov
Journal:  Adv Ther       Date:  2021-04-08       Impact factor: 3.845

6.  Physical activity levels of patients prior to acute coronary syndrome - Experience at a tertiary care hospital in Sri Lanka.

Authors:  A T Matthias; D K N de Silva; J Indrakumar; S B Gunatilake
Journal:  Indian Heart J       Date:  2017-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.